Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
8-Oxoguanine DNA Glycosylase (OGG1) is the primary enzyme responsible for identifying and removing 8-oxoguanine (8-oxoG) lesions from DNA, which are caused by reactive oxygen species (UniProt: O00319). As a key component of the base excision repair (BER) pathway, OGG1 possesses both DNA glycosylase and AP lyase activities to initiate the repair of oxidative damage. Beyond DNA repair, OGG1 plays a significant role in cellular signaling; the complex formed between OGG1 and the excised 8-oxoG base can function as a guanine nucleotide exchange factor, activating Ras GTPases and promoting pro-inflammatory gene expression (PubMed: 30442760). In therapeutic development, OGG1 inhibitors like TH5487 are being investigated for their ability to suppress inflammation and treat various cancers by preventing the recruitment of transcription factors to damaged promoter regions (PubMed: 36379215). Conversely, enhancing OGG1 activity or utilizing mRNA-based delivery systems to increase OGG1 expression is a strategy aimed at protecting cells from age-related oxidative stress and neurodegeneration (PubMed: 35114100). Monitoring OGG1 mRNA and protein levels serves as a critical biomarker for assessing a cell's capacity to handle oxidative stress and its susceptibility to mutagenesis (PubMed: 29155424). The target is also relevant in the context of synthetic lethality, where OGG1 inhibition may selectively kill cancer cells with specific co-existing DNA repair deficiencies. Overall, OGG1 represents a versatile target for both inhibition in inflammatory and oncological contexts and activation in degenerative diseases.
Small molecule inhibition of the OGG1 enzyme prevents the repair of 8-oxoguanine lesions and blocks OGG1-mediated pro-inflammatory signaling pathways. Conversely, OGG1 activators or mRNA-based therapies aim to enhance the excision of oxidative DNA damage to maintain genomic integrity and reduce cellular senescence.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 8-Oxoguanine DNA Glycosylase (OGG1) (OGG1).